BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33827148)

  • 1. Role of FOXO protein's abnormal activation through PI3K/AKT pathway in platinum resistance of ovarian cancer.
    Shi YY; Meng XT; Xu YN; Tian XJ
    J Obstet Gynaecol Res; 2021 Jun; 47(6):1946-1957. PubMed ID: 33827148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis.
    van Boxtel R; Gomez-Puerto C; Mokry M; Eijkelenboom A; van der Vos KE; Nieuwenhuis EE; Burgering BM; Lam EW; Coffer PJ
    Cell Death Differ; 2013 Sep; 20(9):1219-29. PubMed ID: 23832113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt, FoxO and regulation of apoptosis.
    Zhang X; Tang N; Hadden TJ; Rishi AK
    Biochim Biophys Acta; 2011 Nov; 1813(11):1978-86. PubMed ID: 21440011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.
    Dziegielewska B; Casarez EV; Yang WZ; Gray LS; Dziegielewski J; Slack-Davis JK
    Mol Cancer Ther; 2016 Mar; 15(3):460-70. PubMed ID: 26832797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance.
    Gasparri ML; Besharat ZM; Farooqi AA; Khalid S; Taghavi K; Besharat RA; Sabato C; Papadia A; Panici PB; Mueller MD; Ferretti E
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2313-2318. PubMed ID: 30109500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluating the role of FOXOs in cancer.
    Hornsveld M; Dansen TB; Derksen PW; Burgering BMT
    Semin Cancer Biol; 2018 Jun; 50():90-100. PubMed ID: 29175105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pictilisib-Induced Resistance Is Mediated through FOXO1-Dependent Activation of Receptor Tyrosine Kinases in Mucinous Colorectal Adenocarcinoma Cells.
    Kuracha MR; Govindarajan V; Loggie BW; Tobi M; McVicker BL
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
    Nozhat Z; Hedayati M
    Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.
    Paik JH; Kollipara R; Chu G; Ji H; Xiao Y; Ding Z; Miao L; Tothova Z; Horner JW; Carrasco DR; Jiang S; Gilliland DG; Chin L; Wong WH; Castrillon DH; DePinho RA
    Cell; 2007 Jan; 128(2):309-23. PubMed ID: 17254969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to FOXO Biology.
    Link W
    Methods Mol Biol; 2019; 1890():1-9. PubMed ID: 30414140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K/Akt/FoxO: a novel participant in signal transduction in bone cells under mechanical stimulation.
    Ma Y; Wang H
    Cell Biol Int; 2012 Oct; 36(10):923-6. PubMed ID: 22716317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
    Lee S; Choi EJ; Jin C; Kim DH
    Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
    Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
    Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular ATP regulates FoxO family of transcription factors and cell cycle progression through PI3K/Akt in MCF-7 cells.
    Scodelaro Bilbao P; Boland R
    Biochim Biophys Acta; 2013 Oct; 1830(10):4456-69. PubMed ID: 23742826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wortmannin enhances cisplatin-induced apoptosis in human ovarian cancer cells in vitro.
    Zhao JX; Liu H; Lv J; Yang XJ
    Eur Rev Med Pharmacol Sci; 2014; 18(17):2428-34. PubMed ID: 25268086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.
    Chock KL; Allison JM; Shimizu Y; ElShamy WM
    Cancer Res; 2010 Nov; 70(21):8782-91. PubMed ID: 20940403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
    Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
    J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO-independent suppression of programmed cell death by the PI3K/Akt signaling pathway in Drosophila.
    Liu Y; Lehmann M
    Dev Genes Evol; 2006 Sep; 216(9):531-5. PubMed ID: 16520939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resist or die: FOXO transcription factors determine the cellular response to chemotherapy.
    Gomes AR; Brosens JJ; Lam EW
    Cell Cycle; 2008 Oct; 7(20):3133-6. PubMed ID: 18927504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.